Physician profile
Randall Meredith
NPI 1801950712
$1,410.13
in general payments reported to CMS, 2019-2025
14 companies · $49.75 in 2025
The $49.75 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $257 · 2020: $197 · 2021: $285 · 2022: $46.55 · 2023: $286 · 2024: $289 · 2025: $49.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $428.48 | 2023-2025 | Evos, Intellio Link Werewolf, Trigen Intertan |
| Depuy Synthes Sales INC. | $397.07 | 2019-2022 | |
| Horizon Therapeutics Plc | $273.19 | 2019-2022 | |
| Fidia Pharma USA INC. | $115.23 | 2023 | Triluron, Hymovis |
| Heron Therapeutics, INC. | $27.37 | 2021-2023 | Zynrelef |
| Moximed, INC | $27.08 | 2025 | Misha Knee System, Small, Left |
| Ermi LLC | $24.77 | 2019 | |
| Baxter Healthcare | $21.50 | 2023 | Floseal |
| Bioventus LLC | $19.28 | 2021 | |
| Vericel Corporation | $17.53 | 2019 | |
| Convatec INC. | $17.17 | 2021 | |
| Solventum Corporation | $15.67 | 2024 | Prevena, Activ.A.C. |
| Ferring Pharmaceuticals INC. | $14.89 | 2019 | |
| Boston Scientific Corporation | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Meredith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.